Ethnoepidemiology of HTLV-1 related diseases: Ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal

Cancer Science

Volumn 102, Issue 2, 2011, Pages 295-301

  Sonoda, Shunro ^a,b,c   Li, Hong Chuan ^a,d   Tajima, Kazuo ^e  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c Southern Region Hospital   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; DEHYDROXYMETHYLEPOXYQUINOMICIN; FUCOIDIN; HLA ANTIGEN; POLYPHENOL DERIVATIVE;

AFRICA; ANTIVIRAL ACTIVITY; ASIA; BLOOD SAMPLING; BREAST FEEDING; CANCER RESEARCH; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HTLV 1 ASSOCIATED MYELOPATHY; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOPATHOLOGY; MELANESIA; MIGRATION; MOLECULAR MODEL; NORTH AMERICA; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING TEST; SEROLOGY; SOUTH AMERICA; T CELL LEUKEMIA; TROPICAL SPASTIC PARAPARESIS; VERTICAL TRANSMISSION; VIRUS ISOLATION; VIRUS LOAD; VIRUS ONCOGENE; VIRUS TRANSMISSION; WESTERN BLOTTING;

GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; NEOPLASMS;

EID: 79952093148     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01820.x     Document Type: Review

References (79)

1. Sugimura T. Studies on environmental chemical carcinogenesis in Japan. Science 1986; 233(4761): 312-8.
2. Doll R. Hazards of ionizing radiation: 100 years of observations on man. Br J Cancer 1995; 72(6): 1339-49.
3. Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 1911; 13(4): 397-411.
4. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; 1(7335): 702-3.
5. Popovic M, Reitz MS Jr, Sarngadharan MG et al. The virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group. Nature 1982; 300(5887): 63-6.
6. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977; 50(3): 481-92.
7. Hinuma Y, Nagata K, Hanaoka M et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A 1981; 78(10): 6476-80.
8. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 1982; 79(6): 2031-5.
9. Poiesz BJ, Ruscetti FW, Gazdar AF et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980; 77(12): 7415-9.
10. Román GC, Osame M. Identity of HTLV-I-associated tropical spastic paraparesis and HTLV-I-associated myelopathy. Lancet 1988; 1(8586): 651.
11. Mochizuki M, Watanabe T, Yamaguchi K et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992; 83(3): 236-9.
12. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990; 336(8727): 1345-7.
13. Tajima K, Tominaga S, Shimizu H et al. A hypothesis on the etiology of adult T-cell leukemia/lymphoma. Gann 1981; 72(5): 684-91.
14. Sonoda S, Fujiyoshi T, Yashiki S. Immunogenetics of HTLV-I/II and associated diseases. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13 (Suppl 1): S119-23.
15. Yoshida M, Inoue J, Fujisawa J, Seiki M. Molecular mechanisms of regulation of HTLV-1 gene expression and its association with leukemogenesis. Genome 1989; 31(2): 662-7.
16. Gaudray G, Gachon F, Basbous J et al. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J Virol 2002; 76(24): 12813-22.
17. Satou Y, Yasunaga J, Yoshida M et al. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc Natl Acad Sci U S A 2006; 103(3): 720-5.
18. Fukumoto R, Andresen V, Bialuk I et al. In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. Blood 2009; 113(16): 3726-34.
19. Tajima K, Kuroishi T. Estimation of rate of incidence of ATL among ATLV (HTLV-I) carriers in Kyushu, Japan. Jpn J Clin Oncol 1985; 15(2): 423-30.
20. Kaplan JE, Osame M, Kubota H et al. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J Acquir Immune Defic Syndr 1990; 3(11): 1096-101.
21. Bjorgen PJ. MHC restriction in three dimensions: a view of T cell receptor/ligand interactions. Cell 1997; 89: 167-70.
22. Cavalli-Sforza LL, Menozzi P, Piazza A. The History and Geography of Human Genes. Princeton, New Jersey: Princeton University Press, 1994.
23. Tajima K, Sonoda S. Ethnoepidemiology, a new paradigm, for studying cancer risk factors and prevention strategy. In: Tajima K, Sonoda S, eds. Ethnoepidemiology of Cancer. Gann Monograph No.44. Tokyo: Japanese Scientific Societies Press, 1996; 3-12.
24. Kinoshita K, Hino S, Amagaski T et al. Demonstration of adult T-cell leukemia virus antigen in milk from three sero-positive mothers. Gann 1984; 75(2): 103-5.
25. Kusuhara K, Sonoda S et al. Mother-to-child transmission of T-cell leukemia virus type I(HTLV-I): fifteen-year follow-up study in Okinawa, Japan. Int J Cancer 1987; 40: 755-7.
26. Takahashi K, Takezaki T, Oki T et al. Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. The mother-to-child transmission study group. Int J Cancer 1991; 49: 673-7.
27. Takezaki T, Tajima K, Ito M et al. Short-term breast-feeding may reduce the risk of vertical transmission of HTLV-I. The Tsushima ATL Study Group. Leukemia 1997; 11 (Suppl 3): 60-2.
28. Miura T, Fukunaga T, Igarashi T et al. Phylogenetic subtypes of human T-lymphotropic virus type I and their relations to the anthropological background. Proc Natl Acad Sci U S A 1994; 91(3): 1124-7.
29. Li HC, Fujiyoshi T, Lou H et al. The presence of ancient human T-cell lymphotropic virus type I provirus DNA in an Andean mummy. Nat Med 1999; 5(12): 1428-32.
30. Fujiyoshi T, Li HC, Lou H et al. Characteristic distribution of HTLV type I and HTLV type II carriers among native ethnic groups in South America. AIDS Res Hum Retroviruses 1999; 15(14): 1235-9.
31. Hurtado L. A progress report of Bolivian field study: In Monbusho International Scientific Research Program. Special Cancer Research in 1994-1998, Overall Evaluation by Foreign Counterpart, pp 93-95
32. Fujiyama C, Fujiyoshi T, Matsumoto D et al. Evaluation of commercial HTLV-1 test kits by a standard HTLV-1 serum panel. Bull World Health Organ 1995; 73(4): 515-21.
33. Seiki M, Hattori S, Hirayama Y et al. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci U S A 1983; 80(12): 3618-22.
34. Tajima K et al. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer 1990; 45(2): 237-43.
35. Osame M, Janssen R, Kubota H et al. Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 1990; 28(1): 50-6.
36. Zamora T, Zaninovic V, Kajiwara M et al. Antibody to HTLV-I in indigenous inhabitants of the Andes and Amazon regions in Colombia. Jpn J Cancer Res 1990; 81(8): 715-9.
37. Blank A, Yamaguchi K, Blank M et al. Six Colombian patients with adult T-cell leukemia/lymphoma. Leuk Lymphoma 1993; 9(4-5): 407-12.
38. Bartholomew C, Jack N, Edwards J et al. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I- associated myelopathy/tropical spastic paraparesis. J Hum Virol 1998; 1(4): 302-5.
39. Kayembe K, Goubau P, Desmyter J et al. A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution. J Neurol Neurosurg Psychiatry 1990; 53(1): 4-10.
40. Sonoda S. HLA and HTLV: 12th International Histocompatibility Worshop Study. In: Charron D, ed. Genetic Diversity of HLA, Functional and Medical Implication. Paris: EDK Med Sci, Int.Publ, 1997; 429-36.
41. Yashiki S, Fujiyoshi T, Arima N et al. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B* 4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes. AIDS Res Hum Retroviruses 2001; 17(11): 1047-61.
42. Yamano Y, Kitze B, Yashiki S et al. Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis). J Neuroimmunol 1997; 76(1): 50-60.
43. White JD, Johnson JA, Nam JM et al. Distribution of human leukocyte antigens in a population of black patients with human T-cell lymphotrophic virus type I-associated adult T-cell leukemia/lymphoma. Cancer Epidemiol Biomarkers Prev 1996; 5(11): 873-7.
44. LaGrenade L, Sonoda S, Miller W et al. HLA DRB1*DQB1* haplotype in HTLV-I- associated familial infective dermatitis may predict development of HTLV-I-associated myelopathy/tropical spastic paraparesis. Am J Med Genet 1996; 61(1): 37-41.
45. Goedert JJ, Li HC, Gao XJ et al. Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types. Int J Cancer 2007; 121(5): 1092-7.
46. Sabouri AH, Saito M, Usuku K et al. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol 2005; 86: 773-81.
47. Robinson J, Malik A, Parham P et al. IMGT/HLA database--a sequence database for the human major histocompatibility complex. Tissue Antigens 2000; 55(3): 280-7.
48. De Campos-Lima PO, Gavioli R et al. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. Science 1993; 260(5104): 98-100.
49. Hino S, Doi H, Yoshikuni H, Sugiyama H et al. HTLV-I carrier mothers with high-titer antibody are at high risk as a source of infection. Jpn J Cancer Res 1987; 78(11): 1156-8.
50. Wiktor SZ, Pate EJ, Rosenberg PS et al. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J Hum Virol 1997; 1(1): 37-44.
51. Nomura K, Utsunomiya A, Furushou H et al. A family predisposition to adult T-cell leukemia. J Clin Exp Hematop 2006; 46(2): 67-71.
52. Biggar RJ, Ng J, Kim N, Hisada M et al. Human leukocyte antigen concordance and the transmission risk via breast-feeding of human T cell lymphotropic virus type I. J Infect Dis 2006; 193(2): 277-82.
53. Tomaru U, Yamano Y, Nagai M et al. Detection of virus-specific T cells and CD8+ T-cell epitopes by acquisition of peptide-HLA-GFP complexes: analysis of T-cell phenotype and function in chronic viral infections. Nat Med 2003; 9(4): 469-76.
54. Igakura T, Stinchcombe JC, Goon PK et al. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003; 299(5613): 1713-6.
55. HUGO Pan-Asian SNP Consotium. Mapping human genetic diversity in Asia. Science 2009; 326(5959): 1541-5.
56. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M et al. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982; 218(4572): 571-3.
57. Lairmore MD, Jacobson S, Gracia F et al. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci U S A 1990; 87(22): 8840-4.
58. Goubau P, Desmyter J, Ghesquiere J et al. HTLV-II among pygmies. Nature 1992; 359(6392): 201.
59. Mahieux R, Gessain A. The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol Biol (Paris) 2009; 57(2): 161-6.
60. Switzer WM, Salemi M, Qari SH et al. Ancient, independent evo;ution and distinct molecular features of the novel human T-lymphotropic virus type4. Retrovirology 2009; 6: 9.
61. Fujiyama C, Fujiyoshi T, Miura T et al. A new endemic focus of human T lymphotropic virus type II carriers among Orinoco natives in Colombia. J Infect Dis 1993; 168(4): 1075-7.
62. Fujiyoshi T, Yashiki S, Fujiyama C et al. Ethnic segregation of HTLV-I and HTLV-II carriers among South American native Indians. Int J Cancer 1995; 63(4): 510-5.
63. Hjelle B, Appenzeller O, Mills R et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992; 339(8794): 645-6.
64. Ishida T, Hinuma Y. The origin of Japanese HTLV-I. Nature 1986; 322(6079): 504.
65. Yoshida M, Seiki M, Yamaguchi K et al. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A 1984; 81(8): 2534-7.
66. Wong-Staal F, Gallo RC. Human T-lymphotropic retroviruses. Nature 1985; 317(6036): 395-403.
67. Kubota R, Fujiyoshi T, Izumo S et al. Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy. J Neuroimmunol 1993; 42(2): 147-54.
68. Furukawa Y, Fujisawa J, Osame M et al. Frequent clonal proliferation of human T-cell leukemia virus type 1 (HTLV-1)-infected T cells in HTLV-1-associated myelopathy. Blood 1992; 80(4): 1012-6.
69. Watanabe M, Ohsugi T, Shoda M et al. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-kappaB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 2005; 106(7): 2462-71.
70. Haneji K, Matsuda T, Tomita M et al. Fucoidan extracted from Cladosiphon okamuranus Tokida induces apoptosis of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells. Nutr Cancer 2005; 52(2): 189-201.
71. Sonoda J, Koriyama C, Yamamoto S et al. HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking. Cancer Sci 2004; 95(7): 596-601.
72. Utsunomiya A, Miyazaki Y, Takatsuka Y et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27(1): 15-20.
73. Ishida T, Ueda R. CCR4 as a novel molecular target for immunotherapy of cancer. Cancer Sci 2006; 97(11): 1139-46.
74. Kannagi M, Harashima N, Kurihara K et al. Tumor immunity against adult T-cell leukemia. Cancer Sci 2005; 96(5): 249-55.
75. Matsuoka M, Green PL. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 2009; 6: 71.
76. Suemori K, Fujiwara H, Ochi T et al. HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. J Gen Virol 2009; 90 (Pt 8): 1806-11.
77. Sonoda S, Yashiki S, Takahashi K et al. Altered HLA antigens expressed on T and B lymphocytes of adult T-cell leukemia/lymphoma patients and their relatives. Int J Cancer 1987; 40(5): 629-34.
78. Hayashi T, Imai K, Morishita Y et al. Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance. Cancer Res 2006; 66(1): 563-70.
79. Takeuchi O, Akira S. Innate immunity to virus infection. Immunol Rev 2009; 227(1): 75-86.